For each case, an average number of total TILs as well as CD4+ and CD8+ TILs, the percentage of TILs of each component, and the percentage of positive PD1 and PDL1 expression in both tumor cells and TIL was evaluated. The gene discussed is CD8A; the disease is neoplasm.